What does increasing regulatory oversight mean for the pharma supply chain?
The Network Effect
AUGUST 26, 2014
Due to more complex supply chains, policy makers worldwide are enforcing stricter regulations for manufacturing and logistics. Selected manufacturing problems and growing public pressure have caused the US Food and Drug Administration (FDA) to strengthen GMP standards (Good Manufacturing Practices) and control them more strictly.
Let's personalize your content